Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
16 Mar 2018 EMA Recommends Extension of Therapeutic Indications for Denosumab Palliative and supportive care
15 Mar 2018 Patient-Derived Organoids Can Recapitulate Patient Responses in the Clinic Gastrointestinal cancers - Translational research
14 Mar 2018 Depression Treatment Does Not Improve the Survival of Depressed Patients with Cancer Palliative and supportive care
13 Mar 2018 EMA Recommends Contraindication for the Use of the Prostate Cancer Medicine Radium-223 Dichloride with Abiraterone Acetate and Prednisone/Prednisolone Genitourinary cancers - Anticancer agents & Biologic therapy
12 Mar 2018 Withdrawal of Application for a Change to the EU Marketing Authorisation for Idelalisib Haematologic malignancies - Anticancer agents & Biologic therapy
09 Mar 2018 EMA Recommends Extensions of Therapeutic Indications for Bosutinib Haematologic malignancies - Anticancer agents & Biologic therapy
08 Mar 2018 Multidisciplinary Team Care is Associated with Improved Survival in Metastatic GCT Genitourinary cancers
07 Mar 2018 NICE Issues an Advice on Chemotherapy Dose Standardisation Anticancer agents & Biologic therapy
06 Mar 2018 EMA Recommends Granting a Marketing Authorisation for Gemtuzumab Ozogamicin Haematologic malignancies - Anticancer agents & Biologic therapy
05 Mar 2018 TAT 2018: Novel Study Explores the Genomic Landscape of Patients Achieving an Exceptional Response to Targeted Therapy Anticancer agents & Biologic therapy
05 Mar 2018 TAT 2018: Novel App Designed to Facilitate Biomarker-Driven Trials of Targeted Anti-Cancer Agents Personalised medicine
05 Mar 2018 EMA Recommends a Change to the Terms of the Marketing Authorisation for Olaparib Gynaecologic malignancies - Anticancer agents & Biologic therapy
02 Mar 2018 Web-Based Intervention Increases Physical Activity and QoL in Adolescent Cancer Survivors Cancer in Special Situations
01 Mar 2018 Endocrinopathies Induced by Immune Checkpoint Inhibitor Regimens Cancer Immunology and Immunotherapy
28 Feb 2018 FDA Approves Abemaciclib as Initial Therapy for HR-positive HER2-negative Metastatic Breast Cancer Breast cancer - Anticancer agents & Biologic therapy